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PhytosphingomyelinThe aim of this study was to examine how structural properties of different sphingomyelin (SM) analogs af-
fected their substrate properties with sphingomyelinase (SMase) from Bacillus cereus. Using molecular dock-
ing and dynamics simulations (for SMase–SM complex), we then attempted to explain the relationship
between SM structure and enzyme activity. With both micellar and monolayer substrates, 3O-methylated
SM was found not to be degraded by the SMase. 2N-methylated SM was a substrate, but was degraded at
about half the rate of its 2NH–SM control. PhytoPSM was readily hydrolyzed by the enzyme. PSM lacking
one methyl in the phosphocholine head group was a good substrate, but PSM lacking two or three methyls
failed to act as substrates for SMase. Based on literature data, and our docking and MD simulations, we con-
clude that the 3O-methylated PSM fails to interact with Mg2+ and Glu53 in the active site, thus preventing
hydrolysis. Methylation of 2NH was not crucial for binding to the active site, but appeared to interfere with
an induced ﬁt activation of the SMase via interaction with Asp156. An OH on carbon 4 in the long-chain base
of phytoPSM appeared not to interfere with the 3OH interacting with Mg2+ and Glu53 in the active site, and
thus did not interfere with catalysis. Removing two or three methyls from the PSM head group apparently
increased the positive charge on the terminal N signiﬁcantly, which most likely led to ionic interactions
with Glu250 and Glu155 adjacent to the active site. This likely interaction could have misaligned the SM sub-
strate and hindered proper catalysis.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Sphingomyelin (SM) is a major constituent in the outer leaﬂet of
many cell membranes [1–3]. It has been argued that SM and other
sphingolipids, together with cholesterol, form lateral ordered do-
mains (i.e., lipid rafts) in membranes, which are believed to be impor-
tant sites for protein–protein interactions [4–7]. The molecular
structure of SMs dramatically affects how they interact with other
lipids and function in domain formation and thus how they facilitate
protein interactions in membranes [8–14].osylphosphorylethanolamine;
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l rights reserved.SM is synthesized from ceramide and phosphatidylcholine (PC),
by transfer of the PC head group to ceramide [15]. This transfer is cat-
alyzed by SM synthases 1 or 2, and occurs in the Golgi (synthases 1
and 2) and in the plasmamembrane (synthase 2) [16–18]. Ceramides,
on the other hand, are formed in the endoplasmic reticulum from a
long-chain base and a fatty acid [19], and their transfer to Golgi is me-
diated by CERT, a ceramide transfer protein [20–22].
SM can be hydrolyzed to ceramide by at least three different clas-
ses of sphingomyelinase (SMase) enzymes. The acid SMase is mainly
responsible for lysosomal degradation of SM [23], whereas a group of
neutral SMases appear to regulate SM levels in cell membranes, in the
Golgi, and in mitochondria [24,25]. An alkaline SMase, secreted from
intestinal cells, appears to be centrally involved in SM metabolism
in the gastrointestinal tract [26].
During the early days of SMase puriﬁcation from various tissues
and microorganisms it was observed that the enzymes were rather
speciﬁc for SM as substrate, and hydrolyzed e.g., PC very slowly or
not at all [27,28]. The effects of substrate modiﬁcations on SMase ac-
tivity have been examined to some extent before. Bittman and co-
workers showed with a rat brain neutral SMase that modiﬁcation of
the 3OH in SM with a methyl group, or elimination of the 3OH
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log in which the phosphocholine head group was linked to the cer-
amide 1-OH by a sulfur atom instead of an oxygen was, however,
found to be a substrate for SMase from Bacillus cereus [30]. In addi-
tion, synthesis of various SM analogs has been accomplished in search
for SMase inhibitors [31–33].
Chemical modiﬁcation studies with the SMase from B. cereus early
suggested that aspartic and glutamic acids are involved in the catalyt-
ic and adsorptive activities of the enzyme [34]. Further mutagenesis
studies of selected conserved residues in the apparent catalytic site
of SMase from B. cereus further revealed their importance for retain-
ing full enzyme activity for SM hydrolysis [35,36]. Although many of
the human SMase enzymes have been cloned and the genes se-
quenced, crystallographic structures currently exist only for two
SMase enzymes, one for Listeria ivanovii [37], and one for B. cereus
[38]. The accomplishment of structure determination of the B. cereus
SMase made it possible to better understand the role of conserved
amino acid residues for metal ion binding, substrate binding, and ca-
talysis [38]. Recently, the alkaline SMase was homology modeled
according to the crystal structure of a nucleotide pyrophosphate/
phosphodiesterase from Xhantomona saxonopodis [39]. However, the
alkaline SMase shares no sequence homology to other SMases.
We have in this study analyzed the catalytic activity of SMase from
B. cereus, and examined how variation in SM structure (for structures
of molecules used, see Scheme 1) affected hydrolysis rates, and howH
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Scheme 1. Chemical structures of the SM analogs used in the study. The upper row shthe enzyme activity for a speciﬁc substrate molecule could be under-
stood in relation to amolecular ﬁt of the substrate to the substrate bind-
ing site of the enzyme. Enzyme activities were measured both with
micellar and monolayer substrate, and the substrate binding into the
crystal structure of B. cereus SMase [38] was examined by employing
docking and MD simulations.
2. Materials and methods
2.1. Materials
The substrate sphingolipids were prepared either by the Slotte
Laboratory (palmitoyl SM, phytoPSM) or by the Katsumura Laboratory
(all other SM analogs used). PSM was puriﬁed from egg SM (Avanti
Polar Lipids, Alabaster, AL, USA) as described previously [13]. PhytoPSM
was prepared from (2S, 3S, 4R)-2-amino-1,3,4-octadecanetriol-1-
phosphocholine (Avanti Polar Lipids) by linking palmitoyl anhydride
(Sigma-Aldrich, St. Louis, MO, USA) to the free NH2 group, as de-
scribed previously [13,40]. The phytoPSMwas puriﬁed using prepar-
ative reverse-phase HPLC chromatography [13] and identiﬁed using
ESI-MS [13]. NMePSM and OMePSM were prepared as described in
[10]. PSM analogs with modiﬁed head-group structure (CPE-Me3,
CPE-Me2, CPE-Me1, CPE) were prepared as described previously [8].
SMase from B. cereus was obtained from Sigma-Aldrich. Water was
used as aqueous solvent in all studies. All other inorganic and organicH
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Fig. 1. Hydrolysis of SManalogs prepared asmicellar substrates by SMase from Bacillus ce-
reus at 37 °C. The ﬂuorescence assay is described in detail under Materials and methods.
Each sample contained 100 nmol of SM analog, and the reaction was started by injecting
the substrate at time zero. The reaction was followed during 30 min, and the slope for
the last 10 min was calculated by linear regression. The slope for PSM was set to 100%,
and the other slopes are relative to this. Representative curves are shown.
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used were of spectroscopic grade. Water was puriﬁed by reverse
osmosis followed by passage through a Millipore UF Plus water puri-
ﬁcation system having ﬁnal resistivity of 18.2 MΩ cm.
2.2. SMase assay with micellar substrate
To measure substrate properties of SM analogs as micellar sub-
strates, the Amplex® Red Sphingomyelinase Assay Kit (Invitrogen/
Molecular Probes, Eugene, OR, USA) was used. The SM micellar solu-
tion was prepared in 0.2 wt.% Triton X-100 (detergent supplied in the
kit) and subjected to intermittent vortex mixing during a period of
30 min. The substrate micelles had an average diameter of 11±
1 nm, and the size was similar for each of the SM analogs. The ﬁnal
concentrations of reactants in the reaction mix were 35.7 μM SM sub-
strate, 5.7 mU/ml of SMase (none in the blank), 14 μM Amplex Red
reagent, 286 mU/ml of peroxidase, 28.6 mU/ml of choline oxidase,
and 1.14 U/ml of alkaline phosphatase. Substrate and co-enzymes
were tempered to 37 °C before starting the reaction by addition of
SMase. Excitation/emission was at 560/590 nm, respectively.
2.3. SMase assay with monolayer substrate
To test for SMase substrate properties of SM analogs in monolayer
membranes, a previously publishedmethodwas used [41]. Since the in-
terfacial molecular area of SM and its corresponding ceramide is differ-
ent (the ceramide being smaller), degradation of SM substrate in a
monolayer at constant lateral surface pressure will lead to a monolayer
area reduction that is proportional to the amount of SM degraded per
time unit. Brieﬂy, the SM analog (in hexane/2-propanol 3:2 vol) was
spread on phosphate-buffered saline (pH 7.4), and after a 5 minwaiting
period, the monolayer was compressed to a surface pressure of 15 mN/
m using a KSV 3000 surface barostat (KSV Instruments, Helsinki,
Finland). The trough was of a zero-order type with a reaction chamber
and a lipid reservoir. During hydrolysis, the reaction chamber contained
buffer supplemented with 5 mMMgCl2 and 0.3 U of SMase in a volume
of about 30 ml. The surface pressure was maintained at 20 mN/m
during the course of the reaction.
2.4. Computational studies
The structure of PSM was sketched with SYBYL7.3 (Tripos, St.
Louis, MO, USA), and minimized using a conjugate gradient method
(max iterations 100,000) with MMFF94s charges [42] and a dielectric
constant of 10.
The 3D structure of B. cereus SMase (PDB: 2DDR [38]) was ac-
quired from the Protein Data Bank [43]. Peptide chain C of 2DDR
was chosen because it contains structural data for the complete
amino acid sequence. Calcium ions seen in the crystal structure
were replaced with magnesium ions because magnesium ions were
used as cations in the experimental setup. TLEAP in ANTECHAMBER
1.27 [44] was used to add hydrogen atoms into the protein structure.
The docking of PSM was performed ﬂexibly with GOLD 5.0 [45]
using GoldScore scoring function and the most accurate (slow)
option.
The docking conformation of PSM for MD simulation was selected
based on the close proximity of catalytic His296 to the reaction center
(phosphorus).
TLEAP in ANTECHAMBER 1.27 was used to create force ﬁeld pa-
rameters for the protein (ff03) [46] and the ligand (gaff) [47]. The
protein–ligand complex was solvated with a rectangular box of trans-
ferable intermolecular potential three-point water molecules [48]
extending 13 Å in all directions from the sides of the protein. Energy
minimizations and MD simulations were performed with NAMD 2.6
[49].The protein–ligand complex was equilibrated in three steps. First,
water molecules and amino acid side chains were minimized with a
conjugate gradient algorithm, while the rest of the system was kept
in place with the harmonic force of 5 kcal mol−1 Å−2. In the second
minimization step ligand–protein complex and water molecules
were minimized without constraints. As a third step, an MD simula-
tion was run for 360 ps with 2.0 fs time-step at constant temperature
(300 K) and pressure (1 atm). Water molecules and amino acid side
chains were allowed to move, while the rest of the system was re-
strained as in the ﬁrst energy minimization step. Finally, the equili-
brated protein–ligand complex was simulated for 7.2 ns with 1.0 fs
time-step at constant temperature (300 K) and at constant pressure
(1 atm) with the Langevin Piston method. In MD simulations a cut-
off value of 12 Å was used for van der Waals interactions and electro-
statics were treated with the Particle Mesh Ewald (PME)method [50].
The simulations were performed under periodic boundary conditions.
Figs. 3 and 4 were prepared using BODIL [51], MOLSCRIPT v 2.1.2 [52],
and the RASTER3D package [53].3. Results
3.1. Micellar substrate properties of various SM analogs
Using the Amplex® Red Sphingomyelinase Assay Kit we were able
to assess the substrate properties of various SM analogs that had
phosphocholine in their head group. We complemented the kit by
using SMase from B. cereus as the source of the SM hydrolytic activity.
The B. cereus enzyme was used since its 3D structure is known [38].
The Amplex® Red reaction only gives relative information about en-
zyme activity, and hence it was important to compare different sub-
strate analogs using as similar as possible reaction conditions. After
a lag phase of 6–11 min, the reaction appeared to be linear with
time (at least during the ﬁrst 30 min — Fig. 1). When comparing
NMePSM and OMePSM analogs with PSM, it was evident that where-
as NMePSM was a substrate, OMePSM was not. The slope of the
change in ﬂuorescence intensity over time was about 54% for
NMePSM (when the PSM slope was set to 100%). The slope for
OMePSM was about 1% (Fig. 1). Previously, it was shown that an
OMeSM analog was not a substrate for neutral SMase from rat brain
[29]. It was further stated that the OMeSM analog actually behaved
as an inhibitor of neutral SMase from rat brain (IC50 value about
50 μM — [29]). PhytoSM, which has an additional hydroxyl on carbon
4 in the long-chain base, was a good substrate for the SMase from
B. cereus (Fig. 1).
Fig. 3. PSM and its key interactions with SMase from Bacillus cereus. PSM was docked
into the catalytic site of SMase. The enzyme is shown with secondary structures where-
as PSM is shown as ball-and-stick. The 3OH group of PSM coordinates to the magne-
sium ion and donates a hydrogen bond to the carboxylate group of Glu53. The
carbonyl oxygen atom of PSM accepts a hydrogen bond from Lys131. Asp156 forms a
hydrogen bond with 2NH of PSM. For reaction, the catalytic His296 is in the close prox-
imity to phosphorus (green dotted line). Hydrogen bonds and metal coordination are
shown with purple and yellow dotted lines, respectively.
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rate of PSM hydrolysis in the presence or absence of OMePSM. Sub-
strate preparations were made to either include OMePSM in the
PSM micelles (equimolar ratio), or to add OMePSM in separate mi-
celles to the reaction mix (again to an equimolar ratio). The hydroly-
sis of PSM was only marginally affected by the presence of equimolar
amounts of OMePSM in the reaction mix (Fig. 2). Both the slope and
the total ﬂuorescence at 30 min were slightly less when PSM and
OMePSM were in the same micelles, as compared to the situation in
which PSM and OMePSM were in separate micelles. It appears that
binding of OMePSM to the active site of SMase from B. cereus is not
very stable and is fully reversible. Therefore, based on our results,
we do not consider OMePSM to be a potent inhibitor of SMase from
B. cereus.
3.2. Docking of PSM to the active site of SMase from B. cereus
To better understand the substrate properties of some SM analogs,
we docked PSM to the active site of SMase and deduced from the
docking and from MD simulations how substrate structure relates to
substrate properties. Both docking and MD simulations suggest that
the 3OH group of PSM coordinates to the magnesium ion, and simul-
taneously donates a hydrogen bond to the carboxylate group of Glu53
(Fig. 3). Also, we observed that the carbonyl oxygen atom of PSM ac-
cepted a hydrogen bond from Lys131. The docking simulation did not
predict interactions with the 2NH group of PSM. However, during the
MD simulation the nearby loops (Val118–Gly132 and Thr150–
Pro164) adjusted to closer proximity of 2NH. As a result, an induced
ﬁt mechanism (Fig. 4) during the substrate binding appeared to pull
up Asp156 to form a hydrogen bond with 2NH of PSM (Fig. 3). Both
the long-chain base and the N-linked acyl chain of PSM extended
into two directions following the curvature of the protein (Fig. 4).
3.3. Binding of sphingomyelin analogs
Since the 3OH group has a dual role in the binding of substrate to
SMase, and since the reaction center is located next to it, it is expected
that OMePSM cannot successfully bind into the same position as PSM.
Accordingly, SMase fails to degrade OMePSM. Methylation of 2NH is0 5 10 15 20 25 30
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Fig. 2. Hydrolysis of SM analogs prepared as micellar substrates by SMase from Bacillus
cereus at 37 °C in the presence of potential inhibitor. The ﬂuorescence assay is de-
scribed in detail under Materials and methods. Each sample contained 100 nmol of
SM analog (except line 2 with only 50 nmol PSM). The sample represented by line 3
contains 50 nmol PSM and 50 nmol OMePSM, co-mixed in the same micelles. For line
4, the sample contained 50 nmol PSM in one population of micelles, and 50 nmol
OMePSM in another population of micelles. These micelles were admixed at time
zero. The reaction was started by adding substrate at time zero, and was followed dur-
ing 30 min, and the slope for the last 10 min was calculated by linear regression for
each sample. The slope for PSM was set to 100%, and the slopes for lines 2, 3 and 4
were about 80%, 68% and 62%, respectively. Representative curves are shown.likely to interfere with interactions that PSM has with the side chain
of Asp156. The loss of induced ﬁt effect in substrate binding could
lead into similar reduction of enzymatic activity as observed earlier
for Asp156Gly mutation [35].Fig. 4. Induced ﬁt after binding of SM to the active site. MD simulation of the SMase 3D
structure after binding of SM to the active site indicate that loops Val118–Gly132 and
Thr150–Pro164 shift position. Loops shown in blue represent the position before and
loops in red after the MD simulations. The α-carbon of Asp156 is shown in black
ball-and-stick. For other simulation conditions, please refer to the Materials and
methods section.
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Fig. 6. Hydrolysis of monolayer substrates under constant surface pressure conditions
by SMase from Bacillus cereus at 37 °C. Monolayers containing one of the head group
SM analogs (PSM or CPE-Me3, CPE-Me2, CPE-Me1, and CPE) were prepared at the buff-
er/air interface, and the monolayer was compressed to a lateral surface pressure of
15 mN/m. At timce zero, enzyme was added to the subphase (about 10 mU/ml) of
the reaction chamber, and the concomitant reduction of monolayer area was recorded
(positive barrier movement).
478 C. Sergelius et al. / Biochimica et Biophysica Acta 1818 (2012) 474–4803.4. Substrate properties of SM analogs in monolayer membranes
To measure SMase-induced hydrolysis of some head group analogs
of SM, the Amplex® Redmicellar assay could not be used, since choline
oxidase does not recognize other substrates than choline. Instead, we
determined relative hydrolysis using a monolayer assay developed in
our laboratory [41]. The assay was performed under constant lateral
packing density (i.e., constant lateral surface pressure). Hydrolysis re-
sults in smaller monolayer area, since the molecular area requirements
of ceramides are smaller than their corresponding SMprecursors. A typ-
ical PSM degradation curve is shown in Fig. 5, inwhich a small lag phase
can be identiﬁed, followed by a rapid hydrolysis stage, ending with a
condition where substrate availability (and ceramide enrichment)
causes the reaction to slow down markedly. NMePSM was a good sub-
strate even for the monolayer assay, but reaction rates were markedly
slower when compared to PSM. OMePSM was not a substrate for
SMase when presented as a monolayer (data not shown). PhytoPSM
appeared to give a slightly longer lag phase compared to PSM, but oth-
erwise the speed of reaction was comparable to that of PSM. The total
monolayer area change was smaller for phytoPSM than for PSM, sug-
gesting that the difference in molecular area between ceramide and
the precursor SM was smaller for the phytosphingolipid pair when
compared to palmitoylceramide and PSM.
In Fig. 6, we show SMase-induced degradation of three head group
analogs of PSM, and compare their degradation with that of PSM.
When one methyl was removed from the phosphocholine head
group (CPE-Me2), the lag time increased slightly, but the rate of deg-
radation (measured as monolayer area decrease) was fairly similar to
that seen with PSM. Clearly, CPE-Me2 was a good substrate for SMase
from B. cereus, despite the omission of one methyl group from the
phosphocholine head group. However, when two or three methyls
were removed (CPE-Me1 and CPE), the substrate properties were
lost and no degradation by SMase was evident (Fig. 6).
4. Discussion
In this study we have measured SMase activities for different SM
substrates and tried to interpret the SM substrate properties based on
substrate docking and MD simulations. The SM substrates were pre-
sented to SMase in two different ways: either using mixed micelle sub-
strates in Triton X-100, or using substrates as monolayers at the air/
buffer interface.Withmicellar substrates, the SMase activity determina-
tion was based on the oxidation of choline (released as phosphocholine
from the SMhead group by SMase). Although it is possible that different
SM analogswould form different types of mixedmicelles with Triton X-0 2 4 6 8 10 12 14
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Fig. 5. Hydrolysis of monolayer substrates under constant surface pressure conditions
by SMase from Bacillus cereus at 37 °C. Monolayers containing one of the SM analogs
(PSM, phytoPSM or NMePSM) were prepared at the buffer/air interface, and the mono-
layer was compressed to a lateral surface pressure of 15 mN/m. At time zero, enzyme
was added to the subphase (about 10 mU/ml) of the reaction chamber, and the con-
comitant reduction of monolayer area was recorded (positive barrier movement).100, our ﬁnding that all examined mixed SM analog micelles were of
similar size (11±1 nm diameter), suggests that major physical differ-
ences in the substrate micelles were not directly responsible for the ob-
served differences in catalysis rates.With themonolayer assay, absolute
hydrolysis rates are possible to be obtained provided that meanmolec-
ular areas of substrate and product are known [41,54]. We did not have
this information, and therefore our monolayer results are qualitative
and not quantitative.
The active site of SMase from B. cereus is well deﬁned, because of
the crystal structure [38], but also because of mutagenesis studies
on conserved amino acid residues performed before the structure be-
came available [35,36,55,56]. Glu53 is the essential Mg2+ binding
amino acid (cation binding site A), whereas His296 is centrally in-
volved in catalysis [38]. The 3OH of the SM substrate is likely to inter-
act both with Mg2+ and with Glu53 (Fig. 3 and [38]). In light of these
interactions, it is obvious that SMase from B. cereus is active only with
the natural D-erythro SM substrate. Accordingly, it was experimental-
ly shown that both the L-erythro [55,57] and the L-threo [55] SM ana-
logs are not degraded efﬁciently by SMases. It is therefore also not
surprising that methylation of the 3OH in PSM made the SM analog
a non-substrate for SMase from B. cereus. Since the 3-OMe analog of
SM, as well as the 3-deoxy analog of SM, made these substrates unhy-
drolyzable with a rat brain neutral SMase [29], it is likely that the ac-
tive site of that enzyme is similar to the one of B. cereus. Indeed, Glu53
and His296 are conserved in the gene for SMase of both B. cereus and
rat (data not shown).The 3OMe analog of SM was reported to be a
low afﬁnity inhibitor of the rat neutral SMase [29]. While this may
be the case for the rat enzyme, our interpretation of our own results
with the SMase from B. cereus is that the 3O-methylated SM analog
was mainly a non-substrate and affected the hydrolysis of PSM
(when both were present at equimolar ratio) only by diluting the
substrate concentration in the mixed micelles (Fig. 2).
Looking further at the active site of B. cereus SMase, it is probable
that Asp156 and Lys131 stabilized the substrate in the active site by
interacting with the 2-NH and the carbonyl oxygen of the N-linked
acyl chain, respectively (Fig. 3). Methylation of the 2-NH caused the
hydrolysis rate to drop by half (micellar assay, Fig. 1) or even more
(monolayer assay, Fig. 5). It is evident that proper stabilization of
the 2NH and the carbonyl oxygen of the N-linked acyl chain were im-
portant for maintaining the substrate in a proper location for catalysis
to occur efﬁciently. Supporting evidence for this interpretation has
been provided by mutagenesis studies, in which the Asp156 was
changed to Gly. This mutation did not render the enzyme inactive,
but severely reduced catalysis efﬁciency when SM was the substrate
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the active site changes the orientation of loops Val118–Gly132 and
Thr150–Pro164 so that the interaction between Asp156 and the
2NH of SM becomesmore pronounced (Fig. 4). This induced ﬁt is like-
ly to contribute to efﬁcient hydrolysis of a native SM substrate.
Although phytoSM is not a major SM species, other sphingolipids
containing the phyto long-chain base are more common [58–61]. How-
ever, we synthesized the phytoPSM analog and tested its substrate prop-
erties with the SMase from B. cereus. PhytoPSM has an OH-group in the
C4 position, in addition to the 3OH group, in the long-chain base. In phy-
toPSMan internal hydrogen bondmight formbetween the 4OHand2NH
of sphingomyelin or between the 4OH and carbonyl oxygens of the N-
linked acyl chains. If this hydrogen bond forms, induced ﬁt during the
substrate binding does not necessarily occur. However, formation of
this hydrogen bondwould require twisting of both the phytosphingosine
long-chain base and the palmitoyl group of phytoPSM. The alteration of
postures of carbon chains takes time, which could lead to prolonged
lag-time before the hydrolysis reaction can commence. This was actually
the case when phytoPSM was presented to SMase as a monolayer sub-
strate (Fig. 5). A clear difference in lag time between PhytoPSM and
PSM was not evident in the Amplex® Red Sphingomyelinase Assay
(Fig. 1). However, since this assay is indirect (relying on several helper
enzymes before signal is obtained) the lag time information obtained
from the monolayer assay is likely to be more reliable.
Next, we analyzed the substrate properties of SM analogs in which
the number of terminal methyls on the phosphocholine head group
was varied (from three in PSM to zero in ceramide phosphoethanola-
mine). In the previous study with rat brain neutral SMase, Lister and co-
workers also included N-demethyl SM (equals our CPE-Me2) in their
assay [29]. They reported that N-demethyl SM was not an inhibitor,
and was hydrolyzed at a rate one ﬁfth of that seen with SM. We deter-
mined that CPE-Me2 was hydrolyzed at about half the rate of PSM by
the SMase from B. cereus. Qualitatively our results agree with the study
of Lister and coworkers, since CPE-Me2 was demonstrated to be a sub-
strate. However, rates are difﬁcult to compare, since both the enzyme
source and the physical state of the substrate were different. Removing
additional methyls from the terminal N rendered the SM analogs non-
substrates. SM is a zwitterionic phospholipid, which has a partial positive
charge on the terminalN in the head group, and a partial negative charge
on a phosphate oxygen. Removing one, two or all three methyls
strengthens the positive charge on the N. Apparently, when the positive
charge on N becomes strong enough, and steric effects of the terminal
methyls diminish, a new interaction may form between the N of the
head group and the Glu250 adjacent to the active site (Fig. 3). Such an in-
teraction could misalign the SM molecule in the active site, especially
with regard to Glu53 and Mg2+, and hinder catalysis. We believe this
is the likely scenario which could explain why CPE-Me1 and CPE are
non-substrates for SMase.
In conclusion, we have combined enzyme activity measurements
with computational studies to better understand how the structure
of SM affects its substrate properties for a SMase with a known 3D
structure. Proper alignment of the SM substrate to the active site re-
quires a speciﬁc orientation of both the 2NH and the 3OH. The proper
head group volume and charge also appear to be important for cor-
rect alignment of the SM molecule in the active site. It is interesting
to note that while SMase from e.g., B. cereus has a fairly strict sub-
strate requirement, this is not necessarily the case for all phospholi-
pases. A recent enzyme activity/molecular docking study explored
convincingly the molecular reasons for the broad substrate speciﬁcity
of the α-toxin phospholipase C from C. perfringens [62].
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